Literature DB >> 9577484

Childhood pyelonephritis: comparison of gadolinium-enhanced MR imaging and renal cortical scintigraphy for diagnosis.

G J Lonergan1, D J Pennington, J C Morrison, R M Haws, M S Grimley, T C Kao.   

Abstract

PURPOSE: To compare gadolinium-enhanced inversion-recovery magnetic resonance (MR) imaging with renal cortical scintigraphy in the diagnosis of childhood pyelonephritis.
MATERIALS AND METHODS: Thirty-seven patients with fever-producing urinary tract infection underwent gadolinium-enhanced inversion-recovery MR imaging and technetium-99m renal cortical scintigraphy. Each study was read in double-blind fashion by two radiologists. The kidney was divided into three zones, and each was graded as positive, equivocal, or negative for pyelonephritis.
RESULTS: Seventy kidneys (210 zones) were imaged. Twenty-six kidneys (54 zones) had evidence of pyelonephritis at both MR imaging and scintigraphy. Twenty-four kidneys (100 zones) were negative on both studies. Twelve kidneys (42 zones) were positive at MR imaging but negative at scintigraphy, and four kidneys (seven zones) were negative at MR imaging but positive at scintigraphy. The results of MR imaging for pyelonephritis were not equivalent to the results of scintigraphy (P = .001 for renal zones). The proportion of positive agreement between readers for the presence of pyelonephritis was 0.85 and 0.57 for MR imaging and scintigraphy, respectively. The proportion of negative agreement was 0.88 and 0.80 for MR imaging and scintigraphy, respectively.
CONCLUSION: Gadolinium-enhanced inversion-recovery MR imaging enabled detection of more pyelonephritic lesions than did renal cortical scintigraphy and had superior interobserver agreement.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577484     DOI: 10.1148/radiology.207.2.9577484

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Has the time come for a successor to DMSA scintigraphy?

Authors:  Hans Jacobsson
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

Review 2.  [Modern imaging technology for childhood urinary tract infection].

Authors:  M Riccabona; R Fotter
Journal:  Radiologe       Date:  2005-12       Impact factor: 0.635

Review 3.  MR urography in children.

Authors:  J Damien Grattan-Smith; Richard A Jones
Journal:  Pediatr Radiol       Date:  2006-06-22

Review 4.  Urinary tract imaging in infancy.

Authors:  Michael Riccabona
Journal:  Pediatr Radiol       Date:  2009-06

5.  [Imaging in pediatric urology].

Authors:  E Lellig; J Straub; M Riccabona
Journal:  Urologe A       Date:  2015-07       Impact factor: 0.639

6.  Imaging of acute pyelonephritis in the adult.

Authors:  H Stunell; O Buckley; J Feeney; T Geoghegan; R F J Browne; W C Torreggiani
Journal:  Eur Radiol       Date:  2006-08-26       Impact factor: 5.315

7.  MRI and suspected acute pyelonephritis in children: comparison of diffusion-weighted imaging with gadolinium-enhanced T1-weighted imaging.

Authors:  Pierre-Hugues Vivier; Asmaa Sallem; Marion Beurdeley; Ruth P Lim; Julien Leroux; Jérome Caudron; Cyril Coudray; Agnès Liard; Isabelle Michelet; Jean-Nicolas Dacher
Journal:  Eur Radiol       Date:  2013-07-25       Impact factor: 5.315

8.  Power Doppler ultrasonography in the diagnosis of acute childhood pyelonephritis.

Authors:  Raphael Halevy; Vladislav Smolkin; Sergey Bykov; Leonid Chervinsky; Waheeb Sakran; Ariel Koren
Journal:  Pediatr Nephrol       Date:  2004-07-06       Impact factor: 3.714

Review 9.  Evaluation of reflux nephropathy, pyelonephritis and renal dysplasia.

Authors:  J Damien Grattan-Smith; Stephen B Little; Richard A Jones
Journal:  Pediatr Radiol       Date:  2007-12-11

10.  MR imaging of kidneys: functional evaluation using F-15 perfusion imaging.

Authors:  J Damien Grattan-Smith; Marcos R Perez-Bayfield; Richard A Jones; Stephen Little; Bruce Broecker; Edwin A Smith; Hal C Scherz; Andrew J Kirsch
Journal:  Pediatr Radiol       Date:  2003-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.